RYTHM, Inc.
RYTHM, Inc. is a U.S.-based consumer products company focused on hemp-derived THC beverages, edibles, and other branded cannabinoid products. Through its subsidiaries, it also licenses intellectual property and brand rights to third parties, with a portfolio that includes RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green, and Señorita.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueReady-to-drink hemp THC beverages sold under the Señorita and RYTHM brands.
Edible cannabinoid products including gummies and related formats under brands such as incredibles and Beboe.
Brand rights licensed to third parties for manufacturing and distribution in exchange for fees.
Products
Reported · share of revenue- Nonlicensing Revenue55.0 %
- License45.0 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
RYTHM sells to consumers seeking hemp-derived THC alternatives to alcohol and traditional cannabis products, especially in beverage and edible formats. It also serves retail partners and distributors that carry its branded products, as well as a related-party licensee that uses its intellectual property in state-licensed cannabis operations.
Buy Señorita and similar THC beverages as alcohol alternatives for social occasions and relaxation.
Purchase gummies and other ingestible products for convenience, discretion, and brand preference.
Stock and distribute branded products because they want differentiated hemp THC offerings.
Use the company’s brands and intellectual property in exchange for sales-based fees.
Strategy
RYTHM’s strategy centers on repositioning the business around hemp-derived THC beverages and branded consumer products while monetizing its intellectual property through licensing. It is also building distribution through retail partnerships, online channels, and selective geographic expansion where hemp products are permitted.
Beverages are the most visible consumer-facing category and can drive repeat purchases and brand recognition.
A broader portfolio improves shelf presence and reduces reliance on any single product format.
Licensing can extend brand reach without requiring full manufacturing and distribution ownership.
Geography
RYTHM is headquartered in the United States and sells primarily in U.S. states where hemp-derived THC products are permitted. The company also sells Señorita in Canada and has described expansion into additional retail and on-premises channels, making regulatory access a key part of its geographic footprint.
Risks
RYTHM is exposed to regulatory risk because hemp-derived THC products depend on federal, state, and local rules that can change or tighten. The business also faces concentration risk in a narrow product set and limited geographies, plus execution risk around product acceptance, retailer adoption, licensing relationships, and access to financing.
- Federal or state restrictions on hemp-derived THC productsImpact: HighLikelihood: Medium
The company’s core products depend on the legal status of hemp THC and related enforcement interpretations.
Exposure: Hemp-derived THC beverages and edibles
- Geographic concentrationImpact: HighLikelihood: Medium
Sales are limited to jurisdictions that permit hemp-derived THC products, increasing regulatory and market concentration.
Exposure: U.S. states and Canada
- Financing and liquidity accessImpact: HighLikelihood: Medium
The business may need external capital to support working capital and growth, and funding terms may be unfavorable.
Exposure: Working capital and inventory support
- Customer licensing and regulatory compliance riskImpact: MediumLikelihood: Medium
Some customers must maintain licenses to operate, and loss of those licenses can reduce sales and licensing revenue.
Exposure: Retail and licensed cannabis counterparties
- Product acceptance and competitionImpact: MediumLikelihood: Medium
Branded hemp products compete with alcohol, cannabis, and other consumer packaged goods offerings.
Exposure: New beverage and edible launches
Accounting
Judgemental itemsThe company has both physical product revenue and sales-based license revenue, which may be recognized at different times.
Impact: Affects reported revenue mix and quarter-to-quarter comparability
The company reports changes in fair value for warrants and related instruments, which can materially affect non-operating results.
Impact: Can create large non-cash swings in earnings
Goodwill is subject to annual and interim impairment testing based on projected performance and market value.
Impact: Potential for material write-downs if expectations weaken
Recent acquisitions require purchase accounting and valuation of acquired brands and assets.
Impact: Influences intangible assets, amortization, and future impairment risk
Similar listed companies
Publicly listed companies with a comparable business focus.
Rhythm Pharmaceuticals, Inc
RYTM · Pharmaceutical Preparations
Rhythm Pharmaceuticals is a U.S.-based biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders of obesity and related metabolic diseases.
Rithm Property Trust Inc.
RPT-PC · Real Estate Investment Trusts
cbdMD, Inc.
YCBD · Perfumes, Cosmetics & Other Toilet Preparations
Charlotte's Web Holdings, Inc.
CWBHF · Agricultural Production-Crops
Rithm Acquisition Corp.
RAC-WT · Blank Checks
Green Thumb Industries Inc.
GTBIF · Agricultural Production-Crops
Last updated: 24/09/2026